Vincerx Pharma, Inc. Banner Image

Vincerx Pharma, Inc.

  • Ticker VINC
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Vincerx Pharma, Inc. Logo Image
  • 51-200 Employees
  • Based in Palo Alto, California
Vincerx Pharma, Inc. (Vincerx) is a clinical-stage biopharmaceutical company committed to developing differentiated and novel therapies to address the unmet medical needs of patients with cancer. Vincerx has assembled a seasoned management team with a proven track record of successful oncology drug development, approvals, and value creation. Vincerx’s diverse pipeline consists of the next-generationMore antibody drug-conjugate, VIP943, with a pending IND, preclinical antibody drug conjugate, VIP924, small molecule drug-conjugate, VIP236, in Phase 1, CDK9 inhibitor, enitociclib, currently in an NIH-sponsored Phase 1, and its next-generation modular bioconjugation platform.
Vincerx Pharma, Inc.

Most Recent Annual Report

Vincerx Pharma, Inc.
MOST RECENT 2022 Annual Report and Form 10K

Older/Archived Annual Reports

Vincerx Pharma, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!